Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
47.83 EUR | +3.15% | +7.75% | -1.85% |
Mar. 22 | Destabilised French Residential market. | |
Mar. 18 | Covivio: share price rises as HSBC raises its recommendation | CF |
Sales 2024 * | 940M 1.02B | Sales 2025 * | 959M 1.04B | Capitalization | 4.78B 5.16B |
---|---|---|---|---|---|
Net income 2024 * | 66M 71.27M | Net income 2025 * | 587M 634M | EV / Sales 2024 * | 11.9 x |
Net Debt 2024 * | 6.43B 6.95B | Net Debt 2025 * | 6.34B 6.85B | EV / Sales 2025 * | 11.6 x |
P/E ratio 2024 * |
-212
x | P/E ratio 2025 * |
9.47
x | Employees | - |
Yield 2024 * |
7.11% | Yield 2025 * |
7.18% | Free-Float | 66.82% |
Latest transcript on Covivio
1 day | +3.15% | ||
1 week | +7.75% | ||
Current month | +15.20% | ||
1 month | +15.79% | ||
3 months | -3.38% | ||
6 months | +16.51% | ||
Current year | -1.85% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 58 | 01-09-30 | |
Paul Arkwright
DFI | Director of Finance/CFO | 38 | 13-12-31 |
Chief Tech/Sci/R&D Officer | 36 | 18-02-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 70 | 11-01-30 | |
Olivier Piani
BRD | Director/Board Member | 70 | 19-04-16 |
Chief Executive Officer | 58 | 01-09-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 46.5 | +0.25% | 85,213 |
24-03-27 | 46.38 | +1.49% | 296,128 |
24-03-26 | 45.7 | +0.69% | 153,509 |
24-03-25 | 45.39 | -0.53% | 70,432 |
24-03-22 | 45.63 | +2.80% | 370,571 |
Delayed Quote London S.E., March 28, 2024 at 12:30 pm EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-5.78% | 46.59B | |
+1.69% | 22.55B | |
+1.96% | 14.03B | |
+11.33% | 11.19B | |
-3.88% | 9.88B | |
-8.58% | 9.02B | |
-0.90% | 8.47B | |
-2.76% | 7.41B | |
-9.68% | 6.32B |
- Stock
- Equities
- Stock Covivio
- Stock Covivio - London S.E.